Scientific Publications

Selected Publications related to Redbiotec’s technology

  • Ries C, Wasem V, Karrer D, John C, Eibl R (2011)
    A new approach for rapid development of Spodoptera frugiperda/BEVS-based processes
    N. Jenkins et al. (Eds.), Proceedings of the 21st Annual Meeting of the Eurpean Society for Animal Cell Culture Technology (ESACT), Dublin, Ireland, june 7-10, 2009, ESACT Proceedings 5, DOI 10.1007/978-94-007-0884-6_111, Srpinger Sience+Business Media B.V. (in press)
  • Ries C, John C, Eibl R (2010)
    A new scale-down approach for the rapid development of Sf21/BEVS processes – a case study, in Single use technology in Biopharmaceutical Manufacture (Eds. R. Eibl, D. Eibl)Wiley, Weinheim, in production
  • Ries C, John G, John C, Eibl R, Eibl D (2010)
    A shaken disposable bioreactor system for controlled insect cell cultivations at millilitre-scale (short communication)
    Engineering in Life Science 10(1):75-79
  • Ries C, John C, Eibl R (2009)
    Einwegbioreaktoren für Prozessentwicklung mit Insektenzellen
    BioForum 3:11-13
  • Senger T, Schädlich L, Gissmann L, Müller M (2009)
    Enhanced papillomavirus-like particle production in insect cells
    Virology 388 (2009), 344-353
  • Forstner M, Leder L, Mayr L (2007)
    Optimization of protein expression systems for modern drug discovery
    Expert Rev. Proteomics 4(1), 67-78
  • Fitzgerald DJ, Schaffitzel C, Berger P, Wellinger R, Bieniossek C, Richmond TJ, Berger I (2007)
    Multiprotein expression strategy for structural biology of eukaryotic complexes
    Structure (2007), 15(3):275-9
  • Fitzgerald DJ, Berger P, Schaffitzel C, Yamada K, Richmond TJ, Berger I (2006)
    Protein complex expression by using multigene baculoviral vectors
    Nat Methods (2006), 3(12):1021-32
  • Berger I, Fitzgerald DJ, Richmond TJ (2004)
    Baculovirus expression system for heterologous multiprotein complexes.
    Nat Biotechnol. (2004);22(12):1583-7.

Selected Publications by Redbiotec employees

  • Vicente T, Mota JPB, Peixoto C, Alves PM, Carrondo MJT (2011)
    Rational design and optimization of downstream processes of viral particles for biopharmaceutical applications: current advances
    Biotechnology Advances, in press.
  • Vicente T, Roldão A, Peixoto C, Carrondo MJT, Alves PM (2011)
    Large-scale production and purification of VLP-based vaccines
  • Journal of Invertebrate Pathology, in press.
  • Roldão A, Vicente T, Peixoto C, Carrondo MJT, Alves PM (2011)
    Quality control for baculovirus-based products
    Journal of Invertebrate Pathology, in press.
  • Vicente T, Peixoto C, Mota JPB, Carrondo MJT, Alves PM (2011)
    Optimizing Downstream Processing of Enveloped Viruses: Case Study Demonstrates Utility of Inventive Strategies
    Genetic Engineering & Biotechnology News. Bioprocess Tutorial January 15.
  • Bredl, S (2010)
    Modulation der Immunogenität einer auf Gag, Pol und Nef basierenden HIV-1-Vakzine.
    Dissertation, Universität Regensburg, urn:nbn:de:bvb:355-epub-134194
  • Vicente T, Peixoto C, Carrondo MJT, Alves PM (2009)
    Purification of recombinant baculoviruses for gene therapy using membrane processes
    Gene Therapy (2009); 16:766–775
  • Vicente T, Sousa MQ, Peixoto C, Mota JPB, Alves PM, Carrondo MJT (2008)
    Anion exchange membrane chromatography for purification of rotavirus-like particles
    Journal of Membrane Science (2008); 311:270–283.
  • Speth C, Bredl S, Hagleitner M, Wild J, Dierich M, Wolf H, Schroeder J, Wagner R, Deml L. (2008)
    Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators ofhuman monocytes
    Virology (2008); 382(1):46-58.
  • Zuniga A, Wang Z, Liniger M, Hangartner L, Caballero M, Pavlovic J, Wild P, Viret JF, Glueck R, Billeter MA, Naima HY (2007)
    Attenuated measles virus as a vaccine vector
    Vaccine (2007); 25(16):2974-83.
  • Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K (2006)
    Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the Gprotein of vesicular stomatitis virus
    Virology (2006); 351(1):133-44.
  • Wellnitz S, Klumpp B, Barth H, Ito S, Depla E, Dubuisson J, Blum HE, Baumert TF (2002)
    Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human celllines.
    J Virol. (2002); 76(3):1181-93.
  • Baumert TF, Wellnitz S, Aono S, Satoi J, Herion D, Tilman Gerlach J, Pape GR, Lau JY, Hoofnagle JH,Blum HE, Liang TJ (2000)
    Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C
    Hepatology (2000); 32(3):610-7.